Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03243942 · ClinicalTrials.gov registry record · Phase 2

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

A Phase 2 study of Heart Failure and Blood Pressure, sponsored by Thomas Jefferson University.

Completed
Registry status
Phase 2
Development phase
56
Enrollment target
1
Study location

NCT03243942: Completed Phase 2 study of Heart Failure and Blood Pressure, sponsored by Thomas Jefferson University.

NCT03243942 is a Phase 2 study of Heart Failure and Blood Pressure that has completed, run by Thomas Jefferson University. The registered enrollment target is 56 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03243942, a Phase 2 study of Heart Failure and Blood Pressure, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
Phase 2
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The fundamental hypothesis of this project is that real-time intracardiac pressures can be monitored and quantified noninvasively in humans using a novel contrast-enhanced ultrasound technique called subharmonic-aided pressure estimation (SHAPE).This study will use contrast echocardiography to assess the accuracy of SHAPE compared to simultaneously acquired intracardiac pressures measured invasively during cardiac catheterization. This study is designed to verify that contrast echocardiography using the SHAPE method, already proven in a canine model and tested in a human pilot study can be used as a surrogate for cardiac catheterization with sufficient accuracy to allow clinical applicability in humans.

Primary Outcome

Correlation

Interventions

  • DRUG Definity

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University and Thomas Jefferson University Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2017-06-01
Est. Completion 2019-06-26
Phase Phase 2
Thomas Jefferson University

292 total trials

What the finished NCT03243942 record still lists

NCT03243942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower).

The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Definity is the first listed.

NCT03243942 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03243942 about?

NCT03243942 is a clinical study titled "Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement". The fundamental hypothesis of this project is that real-time intracardiac pressures can be monitored and quantified noninvasively in humans using a novel contrast-enhanced ultrasound technique called subharmonic-aided pressure estimation (SHAPE).This study will use contrast echocardiography to asses...

What is the current status of trial NCT03243942?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2017-06-01. Estimated completion is 2019-06-26.

What conditions does trial NCT03243942 study?

This clinical trial studies the following conditions: Heart Failure, Blood Pressure, Cardiac Catheterization, Echocardiography, Heart Ventricles.

What interventions are being tested in trial NCT03243942?

The interventions under investigation include: Definity (DRUG).

Who is sponsoring clinical trial NCT03243942?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03243942 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03243942's enrollment target sits among peer trials

56 271st of 397 higher than 126 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03243942, the US trial registry maintained by the National Library of Medicine. NCT03243942 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.